Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
1463528
Title:
INHIBITEURS SELECTIF DE RECAPTAGE DE LA NOREPINEPHRINE ET DE LA SEROTONINE UTILISES DANS LE TRAITEMENT DU SYNDROME DE LA FIBROMYOSITE, DE L'ENCEPHALO-MYELITE MYALGIQUE ET DE LA DOULEUR
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
027938802
WO application number:
US2002035396
Type:
European patent granted for BE
Status:
Expired
Publication number:
1463528
WO publication number:
WO 2003/039598
1rst applicant's nationality:
Translation language:
French
EPO publication language:
English
SPC number:
Dates
Filing date:
05/11/2002
Grant date:
11/04/2012
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
11/07/2012
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
11/04/2012
EP B1 publication date:
11/04/2012
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
05/11/2022
Applicant
1
Name:
Pierre Fabre Médicament
Legal Form:
From:
21/08/2014
Address:
45, Place Abel Gance, 92100 Boulogne-Billancourt, France (FR)
To:
2
Name:
Cypress Bioscience, Inc.
Legal Form:
From:
11/04/2012
Address:
4350 Executive Drive Suite 325, San Diego CA 92121, United States (US)
To:
21/08/2014
3
Name:
SAVELLA AIV LLC
Legal Form:
From:
21/08/2014
Address:
110 East 59th Street, 33rd Floor, N.Y. 10022, New York, New York, United States (US)
To:
21/08/2014
4
Name:
Royalty Pharma Collection Trust
Legal Form:
From:
21/08/2014
Address:
110 East 59th Street, 33rd Floor, New York, N.Y. 10022, United States (US)